Tissue Lipidomic Alterations Induced by Prolonged Dexamethasone Treatment

Muscle disorder
DOI: 10.1021/acs.jproteome.0c00759 Publication Date: 2021-02-09T08:00:50Z
ABSTRACT
Dexamethasone is a synthetic glucocorticoid medication vastly used to treat abnormal immune responses and inflammation. Although the well-established in medical community, prolonged treatment with high dosages of dexamethasone may lead severe adverse effects through mechanisms that are not yet well-known. Lipids large class hydrophobic molecules involved energy storage, signaling, modulation gene expression, membranes. Hence, untargeted lipidomics help unravel biochemical alterations following dexamethasone. We performed comprehensive lipidomic analyses brain, heart, kidney, liver, muscle samples obtained from rats were treated intramuscular injections for 14 weeks compared healthy controls. The employed methodology statistical analysis showed phosphatidic acids, glycerophospholipids, plasmalogens, fatty acids deeply affected by use medication. Brain tissue was only mildly affected, but skeletal strong accumulation lipids be correlated metabolism, myopathy, oxidative processes. This work provides new insights into action one most commonly prescribed drugs world.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (73)
CITATIONS (12)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....